Arkolith/Insider Trading/COGT/Form 4

Fairmount Funds Management LLC

DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Jul 14, 2025
Net Buying
Open-Market Buys
$25.0M
Open-Market Sells
$0
Net Open-Market Flow
$25.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2025Buy(P)2.8M$9.00$25.0M9.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-067758) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML